The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...

The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...

CR’s protein powder investigation inspired a lot of comment and debate. Here, we address the most frequently asked questions.

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

(Reuters) -Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene shareholders were defrauded ...

An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...

Shares of Biohaven fell more than 40% on Wednesday after the U.S. Food and Drug Administration declined to approve its experimental treatment for a rare brain disorder.

Dreyer’s Grand Ice Cream Inc. is recalling a limited number of its Häagen-Dazs Chocolate Dark Chocolate Mini Bars that may ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

Dreyer’s Grand Ice Cream has recalled some Häagen-Dazs Chocolate Dark Chocolate Mini Bars because of undeclared wheat. The ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.